Search OPK
OPKO Health, Inc.
NasdaqGS · CIK 944809
Last close1.56
Daily change-0.01 (-0.64%)
10 Years gain-85.41%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
OPK · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
35.6Momentum
n/aAcceleration
n/aConfidence
71.0Annual Revenue17
Quarterly Revenue79
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality14.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet11.3 / 15
Shareholder Economics8.4 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 4.1547%.
Key Metrics
Revenue Growth TTM-11.47%OK
Revenue CAGR 3Y-15.45%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-4.15%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $606.88M | $205.94M | -$117.41M | -$178.54M | -$190.82M | 33.93% | -19.35% | -31.44% | -7.07% | 751.13M |
| 2025 FY Dec 31, 2024 | $713.14M | $218.51M | -$152.07M | -$183.49M | -$208.50M | 30.64% | -21.32% | -29.24% | -9% | 694.02M |
| 2025 FY Dec 31, 2023 | $863.50M | $318.13M | -$157.02M | -$28.20M | -$44.47M | 36.84% | -18.18% | -5.15% | -8.39% | 751.77M |
| 2024 FY Dec 31, 2022 | $1.00B | $288.22M | -$226.25M | -$95.19M | -$119.77M | 28.7% | -22.53% | -11.93% | -10.45% | n/a |
| 2023 FY Dec 31, 2021 | $1.77B | $1.77B | $18.75M | $38.34M | $6.18M | 100% | 1.06% | 0.35% | 0.82% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $587.90M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-076596, 0001193125-26-374421 |
| Revenue Growth TTM | -11.47% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-076596, 0001193125-26-374421 |
| Revenue CAGR 3Y | -15.45% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-076596 |
| Revenue CAGR 5Y | -15.82% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-076596 |
| Gross Profit CAGR 3Y | -10.6% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-076596 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-374509 |
| Current Ratio | 3.35x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.86x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-374509 |
| Revenue per Diluted Share | $0.78 | Revenue / Diluted Shares | OK | 0001193125-26-076596, 0001193125-26-374421 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001193125-26-076596 |
| Diluted EPS TTM | -$0.10 | Net income TTM / Diluted shares | OK | 0001193125-26-076596, 0001193125-26-374421 |